LT2016100A - Dimerinis antikūno fragmentas, neutralizuojantis vaginolizino citolitinį aktyvumą - Google Patents

Dimerinis antikūno fragmentas, neutralizuojantis vaginolizino citolitinį aktyvumą

Info

Publication number
LT2016100A
LT2016100A LT2016100A LT2016100A LT2016100A LT 2016100 A LT2016100 A LT 2016100A LT 2016100 A LT2016100 A LT 2016100A LT 2016100 A LT2016100 A LT 2016100A LT 2016100 A LT2016100 A LT 2016100A
Authority
LT
Lithuania
Prior art keywords
vaginolysin
neutralizing
antibody fragment
dimeric antibody
cytolytic activity
Prior art date
Application number
LT2016100A
Other languages
English (en)
Other versions
LT6389B (lt
Inventor
Aurimas Baranauskas
Žilvinas DAPKŪNAS
Gabrielė NEKRAŠĖ
Henrikas Jonas PESLIAKAS
Edita MIŠTINIENĖ
Gitana MICKIENĖ
Gintautas ŽVIRBLIS
Original Assignee
Uab Profarma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab Profarma filed Critical Uab Profarma
Priority to LT2016100A priority Critical patent/LT6389B/lt
Publication of LT2016100A publication Critical patent/LT2016100A/lt
Publication of LT6389B publication Critical patent/LT6389B/lt

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Genetiniais metodais sukonstruoti ir išgryninti nauji dimeriniai antikūno fragmentai prieš vaginoliziną, kurie efektyviai neutralizuoja citolizinį vaginolizino poveikį žmogaus ląstelėms ir gali būti naudojami Gardnerella vaginalis sukeltos bakterinės vaginozės profilaktikai ir (arba) gydymui.
LT2016100A 2016-10-03 2016-10-03 Dimerinis antikūno fragmentas, neutralizuojantis vaginolizino citolitinį aktyvumą LT6389B (lt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LT2016100A LT6389B (lt) 2016-10-03 2016-10-03 Dimerinis antikūno fragmentas, neutralizuojantis vaginolizino citolitinį aktyvumą

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LT2016100A LT6389B (lt) 2016-10-03 2016-10-03 Dimerinis antikūno fragmentas, neutralizuojantis vaginolizino citolitinį aktyvumą

Publications (2)

Publication Number Publication Date
LT2016100A true LT2016100A (lt) 2017-04-10
LT6389B LT6389B (lt) 2017-05-10

Family

ID=58463981

Family Applications (1)

Application Number Title Priority Date Filing Date
LT2016100A LT6389B (lt) 2016-10-03 2016-10-03 Dimerinis antikūno fragmentas, neutralizuojantis vaginolizino citolitinį aktyvumą

Country Status (1)

Country Link
LT (1) LT6389B (lt)

Also Published As

Publication number Publication date
LT6389B (lt) 2017-05-10

Similar Documents

Publication Publication Date Title
CY1122344T1 (el) Blautia stercosis και wexlerae για χρηση στην θεραπευτικη αγωγη φλεγμονωδων και αυτοανοσων νοσων
ZA201903327B (en) Compositions and methods for the induction of cd8+ t¿cells
MX2021006581A (es) Bacterias modificadas para tratar enfermedades asociadas con hiperamonemia.
MX2022010623A (es) Terapias de combinacion que comprenden un receptor quimerico de antigeno cd19 para el cancer.
MX2021013837A (es) Enfoque de inmunoterapias de combinacion para el tratamiento del cancer.
MX2016011132A (es) Métodos para tratar una infección cutánea mediante la administración de un antagonista de il-4r.
EP4252851A3 (en) Ezh2 inhibitors for treating lymphoma
MX2020009780A (es) Compuestos de inhibidor de autotaxina.
MX2017007973A (es) Tratamiento de penfigo.
MX2021006734A (es) Metodo para tratar el cancer.
BR112015019995A2 (pt) Combinação terapêutica envolvendo anticorpos contra claudina 18.2 para tratamento de câncer
GB2541571A (en) Pharmaceutical compositions
NZ631701A (en) Apoptosis-including agents for the treatment of cancer and immune and autoimmune diseases
EA201691845A1 (ru) Фармацевтические композиции терапевтически активных соединений
EA201691844A1 (ru) Фармацевтические композиции терапевтически активных соединений
MX2020009736A (es) Composiciones que comprenden cepas bacterianas.
EP3707275A4 (en) DOSAGE AND STRATEGY RECOMMENDATIONS FOR THE TREATMENT OF MEDICAL CONDITIONS USING CANNABIS
EP3678640A4 (en) METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY SKIN DISEASE
PH12016501371A1 (en) Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same
MX2017014456A (es) Usos terapeuticos de l-4-cloroquinurenina.
PH12020551573A1 (en) Pharmaceutical compositions for inhibiting inflammatory cytokines
ZA201703467B (en) Methods of treating ocular conditions
MX363631B (es) Composiciones y metodos para tratar infecciones bacterianas.
AU2016323967A8 (en) Compositions and methods for the treatment and prevention of radiation dermatitis
LT2016100A (lt) Dimerinis antikūno fragmentas, neutralizuojantis vaginolizino citolitinį aktyvumą

Legal Events

Date Code Title Description
BB1A Patent application published

Effective date: 20170410

FG9A Patent granted

Effective date: 20170510

MM9A Lapsed patents

Effective date: 20191003